Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):986-8. doi: 10.1016/j.ijrobp.2015.09.002. Epub 2015 Nov 11.

Authors

Sue S Yom¹, Maura L Gillison², Andy M Trotti³

Affiliations

¹ Department of Radiation Oncology, University of California, San Francisco, San Francisco, California. Electronic address: yoms@radonc.ucsf.edu.
² Department of Internal Medicine, Ohio State University, Columbus, Ohio.
³ Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.

PMID: 26581136
DOI: 10.1016/j.ijrobp.2015.09.002

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Squamous Cell / therapy*
Chemoradiotherapy / methods*
Female
Humans
Male
Oropharyngeal Neoplasms / therapy*
Papillomavirus Infections / complications*
Radiotherapy, Intensity-Modulated / methods*